This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Abdullahi A., Amini-Nik S., Jeschke M.G.: Animal models in burn research. Cell Mol Life Sci 2014, 71, 3241–3255, doi: 10.1007/s00018-014-1612-5.AbdullahiA.Amini-NikS.JeschkeM.G.Animal models in burn researchCell Mol Life Sci2014713241325510.1007/s00018-014-1612-5413442224714880Open DOISearch in Google Scholar
Ansell D.M., Holden K.A., Hardman M.J.: Animal models of wound repair: Are they cutting it?, Exp Dermatol 2012, 21, 581–585, doi: 10.1111/j.1600-0625.2012.01540.x.AnsellD.M.HoldenK.A.HardmanM.J.Animal models of wound repair: Are they cutting it?Exp Dermatol20122158158510.1111/j.1600-0625.2012.01540.x22775993Open DOISearch in Google Scholar
Barbero A.M. Frasch H.F.: Pig and guinea pig skin as surrogates for human in vitro penetration studies: a quantitative review. Toxicol In Vitro 2009, 23, 1–13, doi: 10.1016/j.tiv.2008.10.008.BarberoA.M.FraschH.F.Pig and guinea pig skin as surrogates for human in vitro penetration studies: a quantitative reviewToxicol In Vitro20092311310.1016/j.tiv.2008.10.00819013230Open DOISearch in Google Scholar
Bhogal R.K. Bona C.A.: Regulatory effect of extracellular signal-regulated kinases (ERK) on type I collagen synthesis in human dermal fibroblasts stimulated by IL-4 and IL-13. Int Rev Immunol 2008, 27, 472–496, doi: 10.1080/08830180802430974.BhogalR.K.BonaC.A.Regulatory effect of extracellular signal-regulated kinases (ERK) on type I collagen synthesis in human dermal fibroblasts stimulated by IL-4 and IL-13Int Rev Immunol20082747249610.1080/0883018080243097419065352Open DOISearch in Google Scholar
Bieber T.: Atopic dermatitis. N Engl J Med 2008, 358, 1483–1494, doi: 10.1056/NEJMra074081.BieberT.Atopic dermatitisN Engl J Med20083581483149410.1056/NEJMra07408118385500Open DOISearch in Google Scholar
Chan L.S., Robinson N., Xu L.: Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis. J Invest Dermatol 2001, 117, 977–983, doi: 10.1046/j.0022-202x.2001.01484.x.ChanL.S.RobinsonN.XuL.Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitisJ Invest Dermatol200111797798310.1046/j.0022-202x.2001.01484.x11676841Open DOISearch in Google Scholar
Del Rosso J.Q.: Monoclonal Antibody Therapies for Atopic Dermatitis: Where Are We Now in the Spectrum of Disease Management? J Clin Aesthet Dermatol 2019, 12, 39–41.DelRosso J.Q.Monoclonal Antibody Therapies for Atopic Dermatitis: Where Are We Now in the Spectrum of Disease Management?J Clin Aesthet Dermatol2019123941Search in Google Scholar
Dillon S.R., Sprecher C., Hammond A., Bilsborough J., Rosenfeld-Franklin M., Presnell S.R., Haugen H.S., Maurer M., Harder B., Johnston J., Bort S., Mudri S., Kuijper J.L., Bukowski T., Shea P., Dong D.L., Dasovich M., Grant F.J., Lockwood L., Levin S.D., LeCiel C., Waggie K., Day H., Topouzis S., Kramer J., Kuestner R., Chen Z., Foster D., Parrish-Novak J., Gross J.A.: Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 2004, 5, 752–760, doi: 10.1038/ni1084.DillonS.R.SprecherC.HammondA.BilsboroughJ.Rosenfeld-FranklinM.PresnellS.R.HaugenH.S.MaurerM.HarderB.JohnstonJ.BortS.MudriS.KuijperJ.L.BukowskiT.SheaP.DongD.L.DasovichM.GrantF.J.LockwoodL.LevinS.D.LeCielC.WaggieK.DayH.TopouzisS.KramerJ.KuestnerR.ChenZ.FosterD.Parrish-NovakJ.GrossJ.A.Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in miceNat Immunol2004575276010.1038/ni108415184896Open DOISearch in Google Scholar
Elias P.M.: Skin barrier function. Curr Allergy Asthma Rep 2008, 8, 299–305, doi: 10.1007/s11882-008-0048-0.EliasP.M.Skin barrier functionCurr Allergy Asthma Rep2008829930510.1007/s11882-008-0048-0284341218606081Open DOISearch in Google Scholar
Fukunaga A., Khaskhely N.M., Sreevidya C.S., Byrne S.N., Ullrich S.E.: Dermal dendritic cells, and not Langerhans cells, play an essential role in inducing an immune response. J Immunol 2008, 180, 3057–3064, doi: 10.4049/jimmunol.180.5.3057.FukunagaA.KhaskhelyN.M.SreevidyaC.S.ByrneS.N.UllrichS.E.Dermal dendritic cells, and not Langerhans cells, play an essential role in inducing an immune responseJ Immunol20081803057306410.4049/jimmunol.180.5.3057240837718292528Open DOISearch in Google Scholar
Godin B.,Touitou E.: Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models. Adv Drug Deliv Rev 2007, 59, 1152–1161, doi: 10.1016/j.addr.2007.07.004.GodinB.TouitouE.Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal modelsAdv Drug Deliv Rev2007591152116110.1016/j.addr.2007.07.00417889400Open DOISearch in Google Scholar
Griffiths C.E., Esmann J., Fisher G.J., Voorhees J.J., Nickoloff B.J.: Differential modulation of keratinocyte intercellular adhesion molecule-I expression by gamma interferon and phorbol ester: evidence for involvement of protein kinase C signal transduction. Br J Dermatol 1990, 122, 333–42, doi: 10.1111/j.1365-2133.1990.tb08281.x.GriffithsC.E.EsmannJ.FisherG.J.VoorheesJ.J.NickoloffB.J.Differential modulation of keratinocyte intercellular adhesion molecule-I expression by gamma interferon and phorbol ester: evidence for involvement of protein kinase C signal transductionBr J Dermatol19901223334210.1111/j.1365-2133.1990.tb08281.xOpen DOISearch in Google Scholar
Hammond S.A., Tsonis C., Sellins K., Rushlow K., Scharton-Kersten T., Colditz I., Glenn G.M.: Transcutaneous immunization of domestic animals: opportunities and challenges. Adv Drug Deliv Rev 2000, 43, 45–55, doi: 10.1016/s0169-409x(00)00076-4.HammondS.A.TsonisC.SellinsK.RushlowK.Scharton-KerstenT.ColditzI.GlennG.M.Transcutaneous immunization of domestic animals: opportunities and challengesAdv Drug Deliv Rev200043455510.1016/s0169-409x(00)00076-4Open DOISearch in Google Scholar
Howell M.D., Fairchild H.R., Kim B.E., Bin L., Boguniewicz M., Redzic J.S., Hansen K.C., Leung D.Y.: Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation. J Invest Dermatol 2008, 128, 2248–2258, doi: 10.1038/jid.2008.74.HowellM.D.FairchildH.R.KimB.E.BinL.BoguniewiczM.RedzicJ.S.HansenK.C.LeungD.Y.Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiationJ Invest Dermatol20081282248225810.1038/jid.2008.74Open DOISearch in Google Scholar
Huang C.H., Kuo I.C., Xu H., Lee Y.S., Chua K.Y.: Mite allergen induces allergic dermatitis with concomitant neurogenic inflammation in mouse. J Invest Dermatol 2003, 121, 289–293, doi: 10.1046/j.1523-1747.2003.12356.x.HuangC.H.KuoI.C.XuH.LeeY.S.ChuaK.Y.Mite allergen induces allergic dermatitis with concomitant neurogenic inflammation in mouseJ Invest Dermatol200312128929310.1046/j.1523-1747.2003.12356.xOpen DOISearch in Google Scholar
Jin H., He R., Oyoshi M., Geha R.S.: Animal models of atopic dermatitis. J Invest Dermatol 2009, 129, 31–40, doi: 10.1038/jid.2008.106.JinH.HeR.OyoshiM.GehaR.S.Animal models of atopic dermatitisJ Invest Dermatol2009129314010.1038/jid.2008.106Open DOISearch in Google Scholar
Jung Y., Son D., Kwon S., Kim J., Han K.: Experimental pig model of clinically relevant wound healing delay by intrinsic factors. Int Wound J 2013, 10, 295–305, doi: 10.1111/j.1742-481X.2012.00976.x.JungY.SonD.KwonS.KimJ.HanK.Experimental pig model of clinically relevant wound healing delay by intrinsic factorsInt Wound J20131029530510.1111/j.1742-481X.2012.00976.xOpen DOISearch in Google Scholar
Kim B.E., Leung D.Y.M.: Significance of Skin Barrier Dysfunction in Atopic Dermatitis. Allergy Asthma Immunol Res 2018, 10, 207–215, doi: 10.4168/aair.2018.10.3.207.KimB.E.LeungD.Y.M.Significance of Skin Barrier Dysfunction in Atopic DermatitisAllergy Asthma Immunol Res20181020721510.4168/aair.2018.10.3.207Open DOISearch in Google Scholar
Kim G.-D., Kim T.-H., Park Y.-S., Ahn H.-J., Cho J.-J., Park C.-S.: Immune response against 2,4-dinitrofluorobenzene-induced atopic dermatitis-like clinical manifestation is suppressed by spermidine in NC/Nga mice. Scand J Immunol 2015, 81, 221–228, doi: 10.1111/sji.12274.KimG.-D.KimT.-H.ParkY.-S.AhnH.-J.ChoJ.-J.ParkC.-S.Immune response against 2,4-dinitrofluorobenzene-induced atopic dermatitis-like clinical manifestation is suppressed by spermidine in NC/Nga miceScand J Immunol20158122122810.1111/sji.12274Open DOISearch in Google Scholar
Kimura M., Tsuruta S., Yoshida T.: Correlation of house dust mite-specific lymphocyte proliferation with IL-5 production, eosinophilia, and the severity of symptoms in infants with atopic dermatitis. J Allergy Clin Immunol 1998, 101, 84–89, doi: 10.1016/S0091-6749(98)70197-6.KimuraM.TsurutaS.YoshidaT.Correlation of house dust mite-specific lymphocyte proliferation with IL-5 production, eosinophilia, and the severity of symptoms in infants with atopic dermatitisJ Allergy Clin Immunol1998101848910.1016/S0091-6749(98)70197-6Open DOISearch in Google Scholar
Kubo A., Nagao K., Amagai M.: Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J Clin Invest 2012, 122, 440–447, doi: 10.1172/JCI57416.KuboA.NagaoK.AmagaiM.Epidermal barrier dysfunction and cutaneous sensitization in atopic diseasesJ Clin Invest201212244044710.1172/JCI57416326678022293182Open DOISearch in Google Scholar
Kurihara-Bergstrom T., Woodworth M., Feisullin S., Beall P.: Characterization of the Yucatan miniature pig skin and small intestine for pharmaceutical applications. Lab Anim Sci 1986, 36, 396–399.Kurihara-BergstromT.WoodworthM.FeisullinS.BeallP.Characterization of the Yucatan miniature pig skin and small intestine for pharmaceutical applicationsLab Anim Sci198636396399Search in Google Scholar
Lavker R.M., Dong G., Zheng P.S., Murphy G.F.: Hairless micropig skin. A novel model for studies of cutaneous biology. Am J Pathol 1991, 138, 687–697.LavkerR.M.DongG.ZhengP.S.MurphyG.F.Hairless micropig skinA novel model for studies of cutaneous biology. Am J Pathol1991138687697Search in Google Scholar
Leung D.Y., Bieber T.: Atopic dermatitis. Lancet 2003, 361, 151–160, doi: 10.1016/S0140-6736(03)12193-9.LeungD.Y.BieberT.Atopic dermatitisLancet200336115116010.1016/S0140-6736(03)12193-9Open DOISearch in Google Scholar
Mahl J.A., Vogel B.E., Court M., Kolopp M., Roman D., Nogués V.: The minipig in dermatotoxicology: methods and challenges. Exp Toxicol Pathol 2006, 57, 341–345, doi: 10.1016/j.etp.2006.03.004.MahlJ.A.VogelB.E.CourtM.KoloppM.RomanD.NoguésV.The minipig in dermatotoxicology: methods and challengesExp Toxicol Pathol20065734134510.1016/j.etp.2006.03.00416713702Open DOISearch in Google Scholar
Man M.Q., Hatano Y., Lee S.H., Man M., Chang S., Feingold K.R., Leung D.Y., Holleran W., Uchida Y., Elias P.M.: Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges. J Invest Dermatol 2008, 128, 79–86, doi: 10.1038/sj.jid.5701011.ManM.Q.HatanoY.LeeS.H.ManM.ChangS.FeingoldK.R.LeungD.Y.HolleranW.UchidaY.EliasP.M.Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challengesJ Invest Dermatol2008128798610.1038/sj.jid.5701011267122917671515Open DOISearch in Google Scholar
Matsuda H., Watanabe N., Geba G.P., Sperl J., Tsudzuki M., Hiroi J., Matsumoto M., Ushio H., Saito S., Askenase P.W., Ra C.: Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 1997, 9, 461–466, doi: 10.1093/intimm/9.3.461.MatsudaH.WatanabeN.GebaG.P.SperlJ.TsudzukiM.HiroiJ.MatsumotoM.UshioH.SaitoS.AskenaseP.W.RaC.Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga miceInt Immunol1997946146610.1093/intimm/9.3.4619088984Open DOISearch in Google Scholar
Matsumoto K., Mizukoshi K., Oyobikawa M., Ohshima H., Tagami H.: Establishment of an atopic dermatitis-like skin model in a hairless mouse by repeated elicitation of contact hypersensitivity that enables to conduct functional analyses of the stratum corneum with various non-invasive biophysical instruments. Skin Res Technol 2004, 10, 122–129, doi: 10.1111/j.1600-0846.2004.00062.x.MatsumotoK.MizukoshiK.OyobikawaM.OhshimaH.TagamiH.Establishment of an atopic dermatitis-like skin model in a hairless mouse by repeated elicitation of contact hypersensitivity that enables to conduct functional analyses of the stratum corneum with various non-invasive biophysical instrumentsSkin Res Technol20041012212910.1111/j.1600-0846.2004.00062.x15059180Open DOISearch in Google Scholar
Meyer W., Schwarz R., Neurand K.: The skin of domestic mammals as a model for the human skin, with special reference to the domestic pig. Curr Probl Dermatol 1978, 7, 39–52, doi: 10.1159/000401274.MeyerW.SchwarzR.NeurandK.The skin of domestic mammals as a model for the human skin, with special reference to the domestic pigCurr Probl Dermatol19787395210.1159/000401274752456Open DOISearch in Google Scholar
Michels G.M., Walsh K.F., Kryda K.A., Mahabir S.P., Walters R.R., Hoevers J.D., Martinon O.M.: A blinded, randomized, placebo-controlled trial of the safety of lokivetmab (ZTS-00103289), a caninized anti-canine IL-31 monoclonal antibody in client-owned dogs with atopic dermatitis. Vet Dermatol 2016, 27, 505–e136, doi: 10.1111/vde.12364.MichelsG.M.WalshK.F.KrydaK.A.MahabirS.P.WaltersR.R.HoeversJ.D.MartinonO.M.A blinded, randomized, placebo-controlled trial of the safety of lokivetmab (ZTS-00103289), a caninized anti-canine IL-31 monoclonal antibody in client-owned dogs with atopic dermatitisVet Dermatol201627505e13610.1111/vde.1236427647513Open DOISearch in Google Scholar
Mori T., Kabashima K., Yoshiki R., Sugita K., Shiraishi N., Onoue A., Kuroda E., Kobayashi M., Yamashita U., Tokura Y.: Cutaneous hypersensitivities to hapten are controlled by IFN-gamma-upregulated keratinocyte Th1 chemokines and IFN-gamma-downregulated langerhans cell Th2 chemokines. J Invest Dermatol 2008, 128, 1719–1727, doi: 10.1038/jid.2008.5.MoriT.KabashimaK.YoshikiR.SugitaK.ShiraishiN.OnoueA.KurodaE.KobayashiM.YamashitaU.TokuraY.Cutaneous hypersensitivities to hapten are controlled by IFN-gamma-upregulated keratinocyte Th1 chemokines and IFN-gamma-downregulated langerhans cell Th2 chemokinesJ Invest Dermatol20081281719172710.1038/jid.2008.518239613Open DOISearch in Google Scholar
Moyaert H., Van Brussel L., Borowski S., Escalada M., Mahabir S.P., Walters R.R., Stegemann M.R.: A blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to ciclosporin in client-owned dogs with atopic dermatitis. Vet Dermatol 2017, 28, 593–e145, doi: 10.1111/vde.12478.MoyaertH.VanBrussel L.BorowskiS.EscaladaM.MahabirS.P.WaltersR.R.StegemannM.R.A blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to ciclosporin in client-owned dogs with atopic dermatitisVet Dermatol201728593e14510.1111/vde.1247828906040Open DOISearch in Google Scholar
Novak N., Bieber T., Leung D.Y.: Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol 2003, 112, S128–139, doi: 10.1016/j.jaci.2003.09.032.NovakN.BieberT.LeungD.Y.Immune mechanisms leading to atopic dermatitisJ Allergy Clin Immunol2003112S12813910.1016/j.jaci.2003.09.03214657843Open DOISearch in Google Scholar
Oyoshi M.K., He R., Kumar L., Yoon J., Geha R.S.: Cellular and molecular mechanisms in atopic dermatitis. Adv Immunol 2009, 102, 135–226, doi: 10.1016/S0065-2776(09)01203-6.OyoshiM.K.HeR.KumarL.YoonJ.GehaR.S.Cellular and molecular mechanisms in atopic dermatitisAdv Immunol200910213522610.1016/S0065-2776(09)01203-6Open DOISearch in Google Scholar
Oyoshi M.K., Murphy G.F., Geha R.S.: Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen. J Allergy Clin Immunol 2009, 124, 485–493, 493.e1, doi: 10.1016/j.jaci.2009.05.042v.OyoshiM.K.MurphyG.F.GehaR.S.Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigenJ Allergy Clin Immunol2009124485493493.e110.1016/j.jaci.2009.05.042vOpen DOISearch in Google Scholar
Paller A., Jaworski J.C., Simpson E.L., Boguniewicz M., Russell J.J., Block J.K., Tofte S., Dunn J.D., Feldman S.R., Clark A.R., Schwartz G., Eichenfield L.F.: Major Comorbidities of Atopic Dermatitis: Beyond Allergic Disorders. Am J Clin Dermatol 2018, 19, 821–838, doi: 10.1007/s40257-018-0383-4.PallerA.JaworskiJ.C.SimpsonE.L.BoguniewiczM.RussellJ.J.BlockJ.K.TofteS.DunnJ.D.FeldmanS.R.ClarkA.R.SchwartzG.EichenfieldL.F.Major Comorbidities of Atopic Dermatitis: Beyond Allergic DisordersAm J Clin Dermatol20181982183810.1007/s40257-018-0383-4Open DOISearch in Google Scholar
Pastore S., Corinti S., La Placa M., Didona B., Girolomoni G.: Interferon-gamma promotes exaggerated cytokine production in keratinocytes cultured from patients with atopic dermatitis. J Allergy Clin Immunol 1998, 101, 538–544, doi: 10.1016/S0091-6749(98)70361-6.PastoreS.CorintiS.LaPlaca M.DidonaB.GirolomoniG.Interferon-gamma promotes exaggerated cytokine production in keratinocytes cultured from patients with atopic dermatitisJ Allergy Clin Immunol199810153854410.1016/S0091-6749(98)70361-6Open DOISearch in Google Scholar
Silverberg J.I.: Association between adult atopic dermatitis, cardiovascular disease, and increased heart attacks in three population-based studies. Allergy 2015, 70, 1300–1308, doi: 10.1111/all.12685.SilverbergJ.I.Association between adult atopic dermatitis, cardiovascular disease, and increased heart attacks in three population-based studiesAllergy2015701300130810.1111/all.1268526148129Open DOISearch in Google Scholar
Souza C.P., Rosychuk R.A.W., Contreras E.T., Schissler J.R., Simpson A.C.: A retrospective analysis of the use of lokivetmab in the management of allergic pruritus in a referral population of 135 dogs in the western USA. Vet Dermatol 2018, 29, 489–e164, doi: 10.1111/vde.12682.SouzaC.P.RosychukR.A.W.ContrerasE.T.SchisslerJ.R.SimpsonA.C.A retrospective analysis of the use of lokivetmab in the management of allergic pruritus in a referral population of 135 dogs in the western USAVet Dermatol201829489e16410.1111/vde.1268230141223Open DOISearch in Google Scholar
Spergel J.M., Mizoguchi E., Brewer J.P., Martin T.R., Bhan A.K., Geha R.S.: Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest 1998, 101, 1614–1622, doi: 10.1172/JCI1647.SpergelJ.M.MizoguchiE.BrewerJ.P.MartinT.R.BhanA.K.GehaR.S.Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in miceJ Clin Invest19981011614162210.1172/JCI16475087429541491Open DOISearch in Google Scholar
Szczepanik M.P., Popiel J., Cekiera A., Pomorska-Handwerker D., Karaś-Tęcza J., Ściskalska M., Oczkowska K., Taube M., Olender V., Parys P.: Evaluation of the clinical efficiency of lokivetmab in client privately owned atopic dogs - multicenter study. Pol J Vet Sci 2020, 23, 191–195, doi: 10.24425/pjvs.2020.132765.SzczepanikM.P.PopielJ.CekieraA.Pomorska-HandwerkerD.Karaś-TęczaJ.ŚciskalskaM.OczkowskaK.TaubeM.OlenderV.ParysP.Evaluation of the clinical efficiency of lokivetmab in client privately owned atopic dogs - multicenter studyPol J Vet Sci20202319119510.24425/pjvs.2020.13276532627992Open DOISearch in Google Scholar
Szczepanik M.P., Wikolek P., Goynski M., Sitkowski W., Taszkun I., Toczek W.: The influence of treatment with lokivetmab on transepidermal water loss (TEWL) in dogs with spontaneously occurring atopic dermatitis. Vet Dermatol 2019, 30, 330–e93, doi: 10.1111/vde.12758.SzczepanikM.P.WikolekP.GoynskiM.SitkowskiW.TaszkunI.ToczekW.The influence of treatment with lokivetmab on transepidermal water loss (TEWL) in dogs with spontaneously occurring atopic dermatitisVet Dermatol201930330e9310.1111/vde.1275831090122Open DOISearch in Google Scholar
Tamamoto-Mochizuki C., Paps J.S., Olivry T.: Proactive maintenance therapy of canine atopic dermatitis with the anti-IL-31 lokivetmab. Can a monoclonal antibody blocking a single cytokine prevent allergy flares?, Vet Dermatol 2019, 30, 98, doi: 10.1111/vde.12715.Tamamoto-MochizukiC.PapsJ.S.OlivryT.Proactive maintenance therapy of canine atopic dermatitis with the anti-IL-31 lokivetmabCan a monoclonal antibody blocking a single cytokine prevent allergy flares?, Vet Dermatol2019309810.1111/vde.1271530672050Open DOISearch in Google Scholar
Vana G., Meingassner J.G.: Morphologic and immunohistochemical features of experimentally induced allergic contact dermatitis in Göttingen minipigs. Vet Pathol 2000, 37, 565–580, doi: 10.1354/vp.37-6-565.VanaG.MeingassnerJ.G.Morphologic and immunohistochemical features of experimentally induced allergic contact dermatitis in Göttingen minipigsVet Pathol20003756558010.1354/vp.37-6-56511105946Open DOISearch in Google Scholar
Vardaxis N.J., Brans T.A., Boon M.E., Kreis R.W., Marres L.M.: Confocal laser scanning microscopy of porcine skin: implications for human wound healing studies. J Anat 1997, 190, 601–611, doi: 10.1046/j.1469-7580.1997.19040601.x.VardaxisN.J.BransT.A.BoonM.E.KreisR.W.MarresL.M.Confocal laser scanning microscopy of porcine skin: implications for human wound healing studiesJ Anat199719060161110.1046/j.1469-7580.1997.19040601.x14676449183682Open DOISearch in Google Scholar